Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Laura Armas, Creighton University
ClinicalTrials.gov Identifier:
NCT01592539
First received: May 3, 2012
Last updated: May 15, 2013
Last verified: May 2013
  Purpose

The effects of high serum glucose on bone could be direct or could be indirect through its effects on the microvasculature. Previous studies by Rendell et al and Brugler et al have found significant differences in skin blood flow between diabetics and control. The investigators are proposing that blood flow measurements of the skin may be correlated with bone remodeling rates in iliac bone biopsies.


Condition
Type 1 Diabetes,
Bone

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls

Resource links provided by NLM:


Further study details as provided by Creighton University:

Estimated Enrollment: 60
Study Start Date: May 2012
Estimated Study Completion Date: October 2013
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
Case
Patients with Type 1 Diabetes Mellitus
Control
Age and sex matched healthy controls.

  Eligibility

Ages Eligible for Study:   19 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients with Type 1 DM

Criteria

Inclusion Criteria:

  • Must have completed a previous study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01592539

Locations
United States, Nebraska
Creighton University
Omaha, Nebraska, United States, 68131
Sponsors and Collaborators
Creighton University
Investigators
Principal Investigator: Laura AG Armas, MD Creighton University
  More Information

No publications provided

Responsible Party: Laura Armas, Assistant Professor, Creighton University
ClinicalTrials.gov Identifier: NCT01592539     History of Changes
Other Study ID Numbers: Creighton11
Study First Received: May 3, 2012
Last Updated: May 15, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Creighton University:
Type 1 Diabetes
Bone

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on September 22, 2014